December 29, 2014 3:38 AM ET

Healthcare Providers and Services

Company Overview of Fox Chase Cancer Center

Company Overview

Fox Chase Cancer Center operates as a cancer research and treatment center in the United States. It provides diagnostic, treatment, research, and prevention services in the areas of breast, colon, lung, and prostate cancer. The company also provides breast evaluation, risk assessment, and diagnostic imaging services; and breast, gynecologic, and ovarian cancer research programs. In addition, it offers screening services, including prevention screening, mammography, skin cancer, Barrett’s esophagus, and open access endoscopy services. Further, the company conducts basic, translational, and clinical research with special programs in cancer prevention, detection, survivorship, and community out...

333 Cottman Avenue

Philadelphia, PA 19111-2497

United States

Founded in 1904





Key Executives for Fox Chase Cancer Center

Chief Executive Officer
Chief Financial Officer
Chief Operating Officer
President of Friends of The Hospital
President of Fox Chase Chapter
Compensation as of Fiscal Year 2014.

Fox Chase Cancer Center Key Developments

Fox Chase Cancer Center Appoints Richard I. Fisher as President and CEO

Richard I. Fisher, MD has been appointed President and CEO of Fox Chase Cancer Center. Fisher will also hold the title of Cancer Center Director of Fox Chase, serving as the principal investigator on the Cancer Center Support Grant (CCSG) from the National Cancer Institute. He will retain the title of Senior Associate Dean for Cancer Programs at Temple University School of Medicine. Since his arrival, Kaiser noted, Fisher has demonstrated extraordinarily adroit and sure-handed leadership and administrative ability, working closely with leaders at Fox Chase and across Temple Health. He has helped to advance a positive and forward-looking perspective that will help to reinvigorate clinical and scientific cancer programs and to launch vital faculty recruitment efforts. Before joining Fox Chase and Temple Health, Fisher was Vice President for Strategic and Program Development at the University of Rochester Medical Center and the Samuel E. Durand Professor of Medicine.

Fox Chase Cancer Center Hires Richard I. Fisher as Executive Vice President

Richard I. Fisher has been hired as executive vice president at Fox Chase Cancer Center, responsible for overseeing and leading the seven clinical-department chairs at the center, a member of the Temple University Health System and Temple University School of Medicine. Fisher had been vice president for strategic and program development at the University of Rochester Medical Center, where he was also Samuel E. Durand professor of medicine.

Fox Chase Cancer Center Announces Offering of New Clinical Test CancerCode-45(TM)

Fox Chase Cancer Center offering patients with advanced cancer a cutting-edge clinical test that will provide them with a unique blueprint of their cancer genes. The new clinical test, known as CancerCode-45(TM), evaluates an individual's tumor for genetic alterations in a select group of 45 genes and gives physicians the opportunity to look at the alterations and be even more precise when choosing a course of treatment. The test is being offered through the Cancer Genome Institute at Fox Chase one of only a few centers in the nation to offer such pioneering technology in cancer molecular diagnostics. Using leading-edge technology, physicians and scientists at Fox Chase are able to perform the CancerCode-45 test and analyze the genetic information in the DNA of a patient's tumor to find changes that are crucial to supporting their cancer. This genetic analysis will examine multiple alterations in 45 cancer-related genes and provide a report to the patient's treating physician. Prior to the CancerCode-45 test being performed, patients will need to see a Fox Chase physician to provide information about their background, medical history, current medications, and ability to perform daily activities. In addition, the physician will need to take a blood sample and a sample of the tumor (which can come from a previous surgery or biopsy that the patient might have had). It takes about 20 working days to get each patient's test results.

Similar Private Companies By Industry

Company Name Region
Gamma Healthcare, Inc. United States
Southern Health Corporation of Ellijay, Inc. United States
DSM Personalized Nutrition, LLC United States
South Arkansas Physician Services, LLC United States
Quintiles Laboratories Limited United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Fox Chase Cancer Center, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at